1. Russell, RG . Bisphosphonates: the first 40 years. Bone. 2011;49(1):2–19.
Google Scholar | Crossref | Medline2. Sharma, P, Chatterjee, P. Response monitoring to bisphosphonate therapy in monostotic Paget disease using (18)F-FDG PET/CT. Clin Nucl Med. 2015;40(6):499–500.
Google Scholar | Crossref | Medline3. Marx, RE . A decade of bisphosphonate bone complications: what it has taught us about bone physiology. Oral Craniofac Tissue Eng. 2012;2(4):309–320.
Google Scholar | Crossref4. Marx, RE . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115–1117.
Google Scholar | Crossref | Medline5. Ruggiero, SL, Dodson, TB, Assael, LA, Landesberg, R, Marx, RE, Mehrotra, B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw—2009 update. J Aust Soc Endodontol Inc. 2009;35(3):119–130.
Google Scholar | Crossref | Medline6. Schwartz, HC . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update and CTX. J Oral Maxillofac Surg. 2015;73(3):377.
Google Scholar | Crossref | Medline7. Marx, RE, Cillo, JE, Ulloa, JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. Official J Am Assoc Oral Maxillofac Surg. 2007;65(12):2397–2410.
Google Scholar | Crossref | Medline8. Otto, S, Pautke, CMD, Hafner, S, et al. Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw—review of the literature and review of our own cases. Craniomaxillofac Trauma Reconstr. 2013;6(3):147–154.
Google Scholar9. García-de Marcos, J, Rey-Biel, J, Submental perforator flap for soft-tissue reconstruction in bisphosphonate-related osteonecrosis of the jaws. Craniomaxillofac Trauma Reconstr. 2017;10(4):299–305.
Google Scholar | SAGE Journals10. Dal Pra, KJ, Lemos, CA, Okamoto, R, Soubhia, AM, Pellizzer, EP. Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review. Int J Oral Maxillofac Surg. 46(2):151–156.
Google Scholar | Crossref | Medline11. Shintani, T, Hayashido, Y, Mukasa, H, et al. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Int J Oral Maxillofac Surg. 2015;44(7):840–844.
Google Scholar | Crossref | Medline12. Hokugo, A, Christensen, R, Chung, EM, et al. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res. 2010;25(6):1337–1349.
Google Scholar | Crossref | Medline13. Biasotto, M, Chiandussi, S, Zacchigna, S, et al. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. J Oral Pathol Med. 2010;39(5):390–396.
Google Scholar | Medline14. Statkievicz, C, Toro, LF, Mello-Neto, JM, et al. Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats. J Photochem Photobiol B. 2018;184:7–17.
Google Scholar | Crossref | Medline15. Sarkarat, F, Motamedi, MHK, Jahanbani, J, Sepehri, D, Kahali, R, Nematollahi, Z. Platelet-rich plasma in treatment of zoledronic acid-induced bisphosphonate-related osteonecrosis of the jaws. Trauma Mon. 2014;19(2):e17196.
Google Scholar | Crossref | Medline16. Barba-Recreo, P, Del Castillo Pardo de Vera, JL, Georgiev-Hristov, T, et al. Adipose-derived stem cells and platelet rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model. J Craniomaxillofac Surg. 2015;43(7):1161–1168.
Google Scholar | Crossref | Medline17. Milinkovic, I, Cordaro, L. Are there specific indications for the different alveolar bone augmentation procedures for implant placement? A systematic review. Int J Oral Maxillofac Surg. 2014;43(5):606–625.
Google Scholar | Crossref | Medline18. Horowitz, R, Holtzclaw, D, Rosen, PS. A review on alveolar ridge preservation following tooth extraction. J Evid Based Dent Pract. 2012;12(3 Suppl):149–160.
Google Scholar | Crossref | Medline19. Traini, T, Degidi, M, Sammons, R, Stanley, P, Piattelli, A. Histologic and elemental microanalytical study of anorganic bovine bone substitution following sinus floor augmentation in humans. J Periodontol. 2008;79(7):1232–1240.
Google Scholar | Crossref | Medline20. Jo, SH, Kim, Y-K, Choi, Y-H. Histological evaluation of the healing process of various bone graft materials after engraftment into the human body. Materials. 2018;11(5):714.
Google Scholar | Crossref21. Jensen, T, Schou, S, Stavropoulos, A, Terheyden, H, Holmstrup, P. Maxillary sinus floor augmentation with Bio-Oss or Bio-Oss mixed with autogenous bone as graft in animals: a systematic review. Int J Oral Maxillofac Surg. 2012;41(1):114–120.
Google Scholar | Crossref | Medline22. Gorla, LdO, Spin-Neto, R, Boos, F, Pereira, RdS, Garcia-Junior, I, Hochuli-Vieira, E. Use of autogenous bone and beta-tricalcium phosphate in maxillary sinus lifting: a prospective, randomized, volumetric computed tomography study. Int J Oral Maxillofac Surg. 2015;44(12):1486–1491.
Google Scholar | Crossref | Medline23. Bonardi, JP, Pereira, R, Lima, FB, et al. Prospective and randomized evaluation of ChronOS and Bio-Oss in human maxillary sinuses: histomorphometric and immunohistochemical assignment for Runx 2, vascular endothelial growth factor, and Osteocalcin. J Oral Maxillofac Surg. 2018;76(2):325–335.
Google Scholar | Crossref | Medline24. Adachi, N, Ayukawa, Y, Yasunami, N, et al. Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw. Sci Rep. 2020;10(1):1–8.
Google Scholar | Crossref | Medline25. Wasserzug, O, Kaffe, I, Lazarovici, TS, et al. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: radiologic aspects. Am J Rhinol Allergy. 2017;31(1):36–39.
Google Scholar | SAGE Journals26. Cardoso, CL, Curra, C, Curi, MM, et al. Treatment of bisphosphonate-related osteonecrosis using platelet-rich plasma: microtomographic, microscopic, and immunohistochemical analyses. Braz Oral Res. 2019;33:e050.
Google Scholar | Crossref | Medline27. Menezes, JD, Pereira, RDS, Bonardi, JP, Griza, GL, Okamoto, R, Hochuli-Vieira, E. Bioactive glass added to autogenous bone graft in maxillary sinus augmentation: a prospective histomorphometric, immunohistochemical, and bone graft resorption assessment. J Appl Oral Sci. 2018;26.
Google Scholar | Crossref | Medline28. Howie, RN, Bhattacharyya, M, Salama, ME, et al. Removal of pamidronate from bone in rats using systemic and local chelation. Arch Oral Biol. 2015;60(12):1699–1707.
Google Scholar | Crossref | Medline29. Zandi, M, Dehghan, A, Zandipoor, N, Amini, P, Doulati, S. Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats. J Craniomaxillofac Surg. 2018;46(3):466–472.
Google Scholar | Crossref | Medline30. Hassumi, JS, Mulinari-Santos, G, Fabris, ALdS, et al. Alveolar bone healing in rats: micro-CT, immunohistochemical and molecular analysis. J Appl Oral Sci. 2018;26:e20170326.
Google Scholar | Crossref | Medline